Karyopharm Therapeutics Inc.盘中异动急速下挫5.01%报0.701美元

市场透视09-24

北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。最近的财报数据显示，该股实现营业收入42.79百万美元，净利润23.79百万美元，每股收益0.20美元，毛利41.23百万美元，市盈率-0.62倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2469147087?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-24 00:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2469147087","market":"us","top_or_hot":-1,"title":"Karyopharm Therapeutics Inc.盘中异动 急速下挫5.01%报0.701美元","media":"市场透视","content":"<div>\n<p>北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。最近的财报数据显示，该股实现营业收入42.79百万美元，净利润23.79百万美元，每股收益0.20美元，毛利41.23百万美元，市盈率-0.62倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Karyopharm Therapeutics Inc.盘中异动 急速下挫5.01%报0.701美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKaryopharm Therapeutics Inc.盘中异动 急速下挫5.01%报0.701美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-24 00:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。最近的财报数据显示，该股实现营业收入42.79百万美元，净利润23.79百万美元，每股收益0.20美元，毛利41.23百万美元，市盈率-0.62倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KPTI","symbol_name":"Karyopharm Therapeutics Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b","article_id":"2469147087","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2469147087","pubTimestamp":1727110048,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.92%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KPTI":"Karyopharm Therapeutics Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Karyopharm Therapeutics Inc. fell sharply 5.01% to $0.701 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KPTI":1,"LENZ":1},"content_text":"北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。最近的财报数据显示，该股实现营业收入42.79百万美元，净利润23.79百万美元，每股收益0.20美元，毛利41.23百万美元，市盈率-0.62倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.92%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Skye Bioscience, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为299.19%、64.22%、63.94%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)，振幅分别为74.90%、57.08%、45.45%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。XPOVIO (selinexor)在美国获批用于多种血液系统恶性肿瘤适应症，包括与Velcade(硼替佐米)和地塞米松联合用于至少接受过一种既往治疗后的多发性骨髓瘤成人患者的治疗，与地塞米松联合治疗患有严重预处理多发性骨髓瘤的成年患者，以及作为单一疗法用于复发或难治性弥漫性大B细胞淋巴瘤成人患者的治疗。该公司的收入来自美国。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2469147087"}

Karyopharm Therapeutics Inc.盘中异动 急速下挫5.01%报0.701美元

精彩评论

Karyopharm Therapeutics Inc.盘中异动急速下挫5.01%报0.701美元